Status:
COMPLETED
Optimisation of the Treatment of Infectious Bursitis
Lead Sponsor:
University Hospital, Geneva
Conditions:
Olecranon Bursitis
Patellar Bursitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study investigates prospectively the cost-savings related to a one-stage bursectomy (debridement, drainage and closure at the same time) versus two-stage bursectomy (debridement, left open and clo...
Detailed Description
Start as single center interventional study at Geneva University Hospitals Study open for additional centres (electronic CRF) Funding on 24.6.2011 (50,000 Swiss Francs). Further demand for funding ong...
Eligibility Criteria
Inclusion
- Age \>18 years
- Hospitalized for bursectomy for septic bursitis
Exclusion
- Bacteraemic diseases
- Presence of another concomitant infection requiring antibiotics
- Presence of osteosynthesis material beneath the bursitis
- Septic bursitis outside of the elbow or the knee
- Severe immune suppression (transplantation, HIV with Cluster of Differentiation cell count \<200 cells/mm3, immune suppressive treatment with equivalence of more than 15 mg of prednisone daily ).
- Recurrent septic bursitis episodes
Key Trial Info
Start Date :
May 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2016
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT01406652
Start Date
May 1 2011
End Date
July 1 2016
Last Update
December 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geneva University Hospitals
Geneva, Switzerland, 1211